-
Min Investment
-
$100
-
Offering Date
-
February 15, 2024
-
Expected Close Date
-
November 15, 2024
-
Target Raise
-
$50.00K-$1.20M
-
No. Investors
-
267
-
Security Price
-
$2
- Number of Employees
- 0
- Cash
- $73,268
- Revenue
- $0
- Short Term Debt
- $3,846,594
- Cost of Goods
- $0
- Long Term Debt
- $2,436,533
- Net Income
- $-1,041,555
Company Description
At SharpMed, we specialize in designing and launching medical devices tailored to doctors' needs and hospital requirements. We rigorously assess the feasibility of each idea, advancing only those with confirmed viability. This streamlined process takes ‘wickedly cool’ ideas and transforms them into fully
Key Deal Facts
Mission: To become the world's #1 medical device incubator.
Founder: Dr. Chris Salvino: 30-year expert in surgery and bioengineering.
Experience: 100 years developing FDA Class I and II medical devices.
Market: $164 billion medical device market.
Products: Bridging the gap between innovative tech and commercial viability
IP: 6 Issued & 16 pending patents.
Capital Goal & Deployment: This raise will initiate our full roster launch.
Management Team / Advisory Board Bios
Chris Salvino
Founder
Ken Andresen
Chief Financial Officer